help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on March 11, 2005, doi:10.1164/rccm.200407-914OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200407-914OCv1
171/11/1246    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasuda, H.
Right arrow Articles by Sasaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuda, H.
Right arrow Articles by Sasaki, H.
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 1246-1251, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200407-914OC

Original Article

Increased Arterial Carboxyhemoglobin Concentrations in Chronic Obstructive Pulmonary Disease

Hiroyasu Yasuda, Mutsuo Yamaya, Katsutoshi Nakayama, Satoru Ebihara, Takahiko Sasaki, Shoji Okinaga, Daisuke Inoue, Masanori Asada, Miyako Nemoto and Hidetada Sasaki

Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, Sendai, Japan

Correspondence and requests for reprints should be addressed to Hiroyasu Yasuda, M.D., Ph.D., Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. E-mail: yasuda{at}geriat.med.tohoku.ac.jp

Rationale: Exhaled carbon monoxide (CO) and arterial blood carboxyhemoglobin concentrations (Hb-CO) increase in inflammatory pulmonary diseases. Objectives: To study whether arterial Hb-CO is useful to monitor disease activity in patients with chronic obstructive pulmonary disease (COPD) who had stopped smoking. Methods: We measured arterial Hb-CO, arteriovenous Hb-CO differences, and FEV1 in 58 patients with COPD and 61 ex-smoking control subjects. Results: Arterial Hb-CO concentrations in patients at stable conditions were higher than those in control subjects (p < 0.0001). Furthermore, the Hb-CO concentrations in patients at the exacerbations (p < 0.0001) were higher than those at the stable conditions. Arterial Hb-CO concentrations in patients at stage III were higher than those in patients at stage II, and the Hb-CO concentrations in patients at stage IV were higher than those in patients at stage III at the stable conditions and exacerbations. Arterial Hb-CO correlated with exhaled CO in patients with COPD at stage II and stage III at the exacerbations. Arterial Hb-CO inversely correlated with the arterial blood partial oxygen pressure and FEV1. Arteriovenous Hb-CO differences in patients at the exacerbations did not differ from those in patients at stable conditions and from those in control subjects. Moreover, arterial Hb-CO correlated with serum C-reactive protein values and serum lipid peroxide concentrations. Conclusions: These findings suggest that increased arterial Hb-CO may relate to severity in patients with COPD because of lung and systemic inflammation and production of reactive oxygen species.

Key Words: carbon monoxide • carboxyhemoglobin • chronic obstructive pulmonary disease • heme oxygenase • systemic inflammation




This article has been cited by other articles:


Home page
 ChestHome page
R. L. Owens, S. Yim-Yeh, and A. Malhotra
Carbon Monoxide Poisoning, or Carbon Monoxide Protection?
Chest, November 1, 2008; 134(5): 895 - 896.
[Full Text] [PDF]

Home page
 ChestHome page
M. Kobayashi, N. Miyazawa, M. Takeno, S. Murakami, Y. Kirino, A. Okouchi, T. Kaneko, and Y. Ishigatsubo
Circulating Carbon Monoxide Level Is Elevated After Sleep in Patients With Obstructive Sleep Apnea
Chest, November 1, 2008; 134(5): 904 - 910.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
G. P. Anderson
The COPD CO-factor
Eur. Respir. J., December 1, 2007; 30(6): 1032 - 1034.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. Sato, M. Takeno, K. Honma, H. Yamauchi, Y. Saito, T. Sasaki, H. Morikubo, Y. Nagashima, S. Takagi, K. Yamanaka, et al.
Heme Oxygenase-1, a Potential Biomarker of Chronic Silicosis, Attenuates Silica-induced Lung Injury
Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 906 - 914.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Update in chronic obstructive pulmonary disease 2005.
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1056 - 1065.
[Full Text] [PDF]

Home page
 ChestHome page
M. Westphal, T. P. Weber, H. Yasuda, M. Yamaya, K. Nakayama, T. Sasaki, S. Ebihara, T. Ebihara, and H. Sasaki
Is the Arteriovenous Carboxyhemoglobin Gradient Really a Useful Marker in Systemic Inflammation?
Chest, November 1, 2005; 128(5): 3771 - 3772.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Permutt and D. B. Pearse
Blood Carbon Monoxide Will Increase from a Decline in Pulmonary Function Alone
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1231 - 1231.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society 		  ATS State of the Art Course 2008